4Asberg,Anders,Midtvedt,et al.Calcineurin inhibitor avoidance with daclizumab,mycophenolate mofetil,and prednisolone in DR-matched de novo kidney transplant recipients[J].Transplantation,2006,82:62-68.
5Kuypers DR,Evenepoel P,Maes B,Coosemans W,Pirenne J,Vanrenterghem Y.The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients[J].Clin Transplant,2003,17:234-241.
6Larsen CP,Knechtle SJ,Adams A,et al.A new look at blockade of T-cell costimulation:a therapeutic strategy for long-term maintenance immunosuppression[J].American Journal of Transplantation,2006,6(5 Pt 1):876-83.
7Berger,Mitchell MPH,Shankar,et al.Therapeutic Applications of Monoclonal Antibodies[J].The American journal of medicine sciences,2002,324(1):14-30.
8Kahan BD,Rajagopalan PR,Hall M.Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab,a chimeric anti-interleukin-2-receptor monoclonal antibody[J].Transplantation,1999,67:276.
9Nashan B,Light S,Hardie IR,et al.Reduction of acute allograft rejection by daclizumab[J].Transplantation,1999,67:110-115.
10Halloran,Philip F.et al.Immunosuppressive agents in clinical trials in transplantation[J].American Journal of Medical Sciences,1997,313:283-288.
